Market revenue in 2023 | USD 76.6 million |
Market revenue in 2030 | USD 178.0 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 59.92% in 2023. Horizon Databook has segmented the India pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
India is expected to emerge as one of the lucrative markets for pharmaceutical sterility testing across the globe. This can be attributed to low costs, the availability of industry experts, and the presence of WHO-cGMP-compliant facilities.
Increasing government funding for R&D to accelerate new product development is expected to improve the number of new drugs in the country, promoting the demand for pharmaceutical sterility testing in India.
Moreover, the Central Government of India introduced a USD 601.39 million (Rs 5,000 crore) initiative to foster R&D in the pharmaceuticals and medical technology sectors. This program includes over Rs 1100 crore funding for research in six priority areas across nine pharmaceutical companies.
Horizon Databook provides a detailed overview of country-level data and insights on the India pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into India pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account